Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

ClinicalTrials.gov ID: NCT03547973

Public ClinicalTrials.gov record NCT03547973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 5, 2026, 10:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer

Study identification

NCT ID: NCT03547973
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Gilead Sciences; Industry
Enrollment: 827 participants

Conditions and interventions

Conditions

Metastatic Urothelial Cancer

Interventions

Avelumab Drug
Carboplatin Drug
Cisplatin Drug
Domvanalimab Drug
Enfortumab Vedotin Drug
Gemcitabine Drug
Pembrolizumab Drug
Sacituzumab Govitecan-hziy Drug
Zimberelimab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 12, 2018
Primary completion: Mar 31, 2030
Completion: Mar 31, 2030
Last update posted: Mar 15, 2026

2018 – 2030

United States locations

U.S. sites: 37
U.S. states: 22
U.S. cities: 35

Facility	City	State	ZIP	Site status
The University of Arizona Cancer Center-North Campus	Tucson	Arizona	85719	Recruiting
USC/Norris Comprehensive Cancer Center	Los Angeles	California	90033	Withdrawn
University of California San Francisco	San Francisco	California	94158	Recruiting
Rocky Mountain Cancer Centers	Littleton	Colorado	80120	Recruiting
Smilow Cancer Hospital at Yale-New Haven	New Haven	Connecticut	06510	Recruiting
Eastern Connecticut Hematology and Oncology Associates	Norwich	Connecticut	06360	Withdrawn
Mount Sinai Comprehensive Cancer Center	Miami Beach	Florida	33140	Recruiting
Woodlands Medical Specialists, PA	Pensacola	Florida	32503	Recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
Winship Cancer Institute, Emory University	Atlanta	Georgia	30322	Completed
University of Illinois Cancer Center	Chicago	Illinois	60612	Recruiting
University of Chicago Medical Center	Chicago	Illinois	60637	Recruiting
Southern Illinois University School of Medicine, Simmons Cancer Institute	Springfield	Illinois	62702	Recruiting
Indiana University Melvin and Bren Simon Cancer Center	Indianapolis	Indiana	46202	Withdrawn
Norton Cancer Institute, Downtown	Louisville	Kentucky	40202	Recruiting
Maryland Oncology Hematology, P.A.	Brandywine	Maryland	20613	Withdrawn
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Karmanos Cancer Institute	Detroit	Michigan	48201	Recruiting
Oncology Hematology West PC dba Nebraska Cancer Specialists	Omaha	Nebraska	68130	Withdrawn
Precision Cancer Research / New Mexico Oncology & Hematology Consultants	Albuquerque	New Mexico	87109	Completed
Roswell Park Cancer Institute	Buffalo	New York	14263	Recruiting
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health	New York	New York	10016	Recruiting
Drug Shipping Address: New York-Presbyterian Hospital	New York	New York	10065	Recruiting
Stony Brook Cancer Center	Stony Brook	New York	11794	Completed
St. Luke's Hosptial - Bethlehem Campus	Easton	Pennsylvania	18045	Recruiting
Medical University of Southern Carolina	Charleston	South Carolina	29425	Recruiting
Thompson Oncology Group - Knoxville West	Knoxville	Tennessee	37932	Recruiting
Henry-Joyce Cancer Clinic	Nashville	Tennessee	37232	Recruiting
Houston Methodist Hospital, Houston Methodist Cancer Center	Houston	Texas	77030	Recruiting
Mays Cancer Center	San Antonio	Texas	78229	Recruiting
Renovatio Clinical	The Woodlands	Texas	77380	Withdrawn
University of Utah - Huntsman Cancer Hospital (IP Shipping Address)	Salt Lake City	Utah	84112	Recruiting
University of Virginia Cancer Center	Charlottesville	Virginia	22903	Withdrawn
Virginia Oncology Associates	Hampton	Virginia	23666	Recruiting
Oncology Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care	Roanoke	Virginia	24014	Recruiting
Seattle Cancer Care Alliance	Seattle	Washington	98109	Recruiting
University of Wisconsin Clinical Science Center	Madison	Wisconsin	53705	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03547973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 15, 2026 · Synced May 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03547973 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →